Oral dosage form of a dabigatran - prodrugs for the treatment of diseases

摘要

The present invention relates to an orally administrable pharmaceutical formulation comprising(i) at least one active ingredient a compound of the formula (Formula 1) in whichR¹ for a - h, a branched or unbranched, saturated or unsaturated, unsubstituted hydrocarbon chain having a chain length of 1 to 12, and n for 2 is;(ii) at least one filler;(iii) at least one binder;(iv), optionally, a flow regulators;(v), optionally, a detonator;(vi), optionally, a lubricant;(vii), optionally, an enteric coating;(viii), optionally, a retarding agent.